Arkolith/Insider Trading/BMEA/Form 4

A2A Pharmaceuticals, Inc.

10% OwnerBiomea Fusion, Inc. (BMEA) · full profile →Form 4 · filed Apr 26, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$5.8M
Net Open-Market Flow
-$5.8M
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 20, 2023Sell(S)200K$29.12$5.8M3.9M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001859061-23-000004) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML